NeoImmuneTech, Inc. (KOSDAQ:950220)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,180.00
+38.00 (3.33%)
Jun 4, 2025, 3:30 PM KST
-33.33%
Market Cap 22.58B
Revenue (ttm) 183.62M
Net Income (ttm) -37.54B
Shares Out 19.77M
EPS (ttm) -380.67
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,175,042
Average Volume 4,937,646
Open 1,151.00
Previous Close 1,142.00
Day's Range 1,123.00 - 1,194.00
52-Week Range 985.00 - 2,090.00
Beta 0.97
RSI 38.15
Earnings Date May 15, 2025

About NeoImmuneTech

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 82
Stock Exchange KOSDAQ
Ticker Symbol 950220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.